192 related articles for article (PubMed ID: 37695398)
1. New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors.
Yun JH; Fang A; Khorshidi F; Habibollahi P; Kutsenko O; Etezadi V; Hunt S; Nezami N
Curr Oncol Rep; 2023 Nov; 25(11):1213-1226. PubMed ID: 37695398
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
Savic LJ; Chapiro J; Hamm B; Gebauer B; Collettini F
Rofo; 2016 Aug; 188(8):735-45. PubMed ID: 27074423
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
Dunki-Jacobs EM; Philips P; Martin RC
Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
[TBL] [Abstract][Full Text] [Related]
4. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
[TBL] [Abstract][Full Text] [Related]
5. Anaesthetic management during open and percutaneous irreversible electroporation.
Nielsen K; Scheffer HJ; Vieveen JM; van Tilborg AA; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR; Bouwman RA
Br J Anaesth; 2014 Dec; 113(6):985-92. PubMed ID: 25173767
[TBL] [Abstract][Full Text] [Related]
6. [Irreversible electroporation: a new form of image-guided tumour ablation].
Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
[TBL] [Abstract][Full Text] [Related]
7. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
8. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
[TBL] [Abstract][Full Text] [Related]
9. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
Front Immunol; 2021; 12():811726. PubMed ID: 35069599
[TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.
Melenhorst MC; Scheffer HJ; Vroomen LG; Kazemier G; van den Tol MP; Meijerink MR
Cardiovasc Intervent Radiol; 2016 Jan; 39(1):117-21. PubMed ID: 25994516
[TBL] [Abstract][Full Text] [Related]
12. Irreversible electroporation: Beyond the limits of tumor ablation.
Alonso-González R; Abadal Villayandre JM; Gálvez Gonzalez E; Álvarez Perez MJ; Méndez Alonso S; de Gregorio Ariza MA
Radiologia (Engl Ed); 2024; 66(1):47-56. PubMed ID: 38365354
[TBL] [Abstract][Full Text] [Related]
13. High-Frequency Irreversible Electroporation: Safety and Efficacy of Next-Generation Irreversible Electroporation Adjacent to Critical Hepatic Structures.
Siddiqui IA; Kirks RC; Latouche EL; DeWitt MR; Swet JH; Baker EH; Vrochides D; Iannitti DA; Davalos RV; McKillop IH
Surg Innov; 2017 Jun; 24(3):276-283. PubMed ID: 28492356
[TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
15. The Enlargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field.
Lv Y; Liu H; Feng Z; Zhang J; Chen G; Yao C
Ann Biomed Eng; 2022 Dec; 50(12):1964-1973. PubMed ID: 35852648
[TBL] [Abstract][Full Text] [Related]
16. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
[TBL] [Abstract][Full Text] [Related]
17. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
[TBL] [Abstract][Full Text] [Related]
19. [Irreversible electroporation: local tumor ablation with systemic immune effect].
Geboers B; Timmer FEF; van den Tol PM; de Gruijl TD; Scheffer HJ; Meijerink MR
Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34854585
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series.
Agnass P; van Veldhuisen E; Vogel JA; Kok HP; de Keijzer MJ; Schooneveldt G; de Haan LR; Klaessens JH; Scheffer HJ; Meijerink MR; van Lienden KP; van Gulik TM; Heger M; Crezee J; Besselink MG
J Clin Transl Res; 2020 Apr; 5(3):109-132. PubMed ID: 32617426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
